PFS
RXRX icon

Prospera Financial Services’s Recursion Pharmaceuticals RXRX Stock Holding History

Prospera Financial Services’s Portfolio RXRX Stock Details RXRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$44.2K Sell
12,056
-61
-0.5% -$203 ﹤0.01% 1454
2026
Q1 		$37.2K Sell
12,117
-3,472
-22% -$13.4K ﹤0.01% 1409
2025
Q4 		$63.7K Buy
+15,589
New +$77.2K ﹤0.01% 1339

Other funds holding RXRX

Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
1WA
180 Wealth Advisors Federal Way, Washington $997M AUM 47.84% 1-Year Est. Return
PL
Plancorp LLC Saint Louis, Missouri $4.1B AUM 25.19% 1-Year Est. Return
Wealth Enhancement Advisory Services
Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return
AWM
Accel Wealth Management Waverly, Iowa $444M AUM 31.14% 1-Year Est. Return
NWMG
National Wealth Management Group Cincinnati, Ohio $323M AUM 39.23% 1-Year Est. Return
WPC
Wedmont Private Capital West Chester, Pennsylvania $3.65B AUM 26.64% 1-Year Est. Return
FFA
Farther Finance Advisors San Francisco, California $12.8B AUM 26.53% 1-Year Est. Return
IIA
Integral Investment Advisors Turlock, California $454M AUM 21.42% 1-Year Est. Return
LA
LVW Advisors Pittsford, New York $1.16B AUM 26.37% 1-Year Est. Return

Prospera Financial Services's RXRX Position: Q2 2026 in Review

Prospera Financial Services reduced its Recursion Pharmaceuticals (RXRX) stake by 0.5% in Q2 2026, selling an estimated $203 and leaving 12,056 shares worth $44.2K. The position accounts for ﹤0.01% of the portfolio, ranked #1454.

Prospera Financial Services first reported a position in RXRX in Q4 2025 and has held it in 3 quarters since. The position peaked at $63.7K in Q4 2025. 24 funds tracked by Wall St. Rank hold RXRX as of Q2 2026.

  • Prospera Financial Services held 12,056 shares of Recursion Pharmaceuticals worth $44.2K as of Q2 2026.
  • Prospera Financial Services sold 61 Recursion Pharmaceuticals shares in Q2 2026, an estimated $203.
  • Recursion Pharmaceuticals made up ﹤0.01% of Prospera Financial Services's portfolio in Q2 2026, its #1454 holding.
  • Prospera Financial Services first reported a position in Recursion Pharmaceuticals in Q4 2025 and has held it in 3 quarters since.
  • Prospera Financial Services's Recursion Pharmaceuticals position peaked at $63.7K in Q4 2025.
  • 24 funds tracked by Wall St. Rank held Recursion Pharmaceuticals as of Q2 2026.

Based on Prospera Financial Services's 13F filing for Q2 2026, filed 15 Jul 2026.